Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.
Sara CostaLurdes SampaioAna Berta SousaChao XingAnil K AgarwalAbhimanyu GargPublished in: The Journal of clinical endocrinology and metabolism (2022)
Concomitant NCAH in this CGL1 patient was associated with precocious pubertal development and sparing of facial fat. Metreleptin therapy drastically improved her hyperglycemia and hyperlipidemia but not menstrual irregularity and hirsutism.